Mesoblast (MESO) FCF Margin Growth (1y) (2017 - 2023)
Mesoblast (MESO) FCF Margin Growth (1y) (2017 - 2023) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
FCF Margin Growth (1y) (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
5,389.00 |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
1,525.00 |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
- |
| 10 |
Mesoblast |
21.68 Bn |
21.55 Bn |
- |
- |
| Date | Value |
|---|
| Jun 30, 2023 |
552,128.00 |
| Mar 31, 2023 |
6,879.00 |
| Dec 31, 2022 |
159,587.00 |
| Sep 30, 2022 |
23,869.00 |
| Jun 30, 2022 |
568,224.00 |
| Mar 31, 2022 |
-633,936.00 |
| Dec 31, 2021 |
59,971.00 |
| Sep 30, 2021 |
290,979.00 |
| Jun 30, 2021 |
-881,480.00 |
| Mar 31, 2021 |
615,260.00 |
| Dec 31, 2020 |
-143,212.00 |
| Sep 30, 2020 |
-298,948.00 |
| Jun 30, 2020 |
457,325.00 |
| Mar 31, 2020 |
-107,746.00 |
| Dec 31, 2019 |
23,427.00 |
| Sep 30, 2019 |
-111,165.00 |
| Jun 30, 2019 |
273,177.00 |
| Mar 31, 2019 |
5,539.00 |
| Dec 31, 2018 |
-110,870.00 |
| Sep 30, 2018 |
367,664.00 |
